TPO-receptor agonists in ITP: a clinician's navigation between Scylla and Charybdis.
作者信息
Rodeghiero Francesco
机构信息
Department of Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy.
出版信息
Am J Hematol. 2012 Oct;87(10):943. doi: 10.1002/ajh.23301. Epub 2012 Jul 27.
PMID:22847599
Abstract
摘要
相似文献
1
TPO-receptor agonists in ITP: a clinician's navigation between Scylla and Charybdis.免疫性血小板减少症中的促血小板生成素受体激动剂：临床医生在斯库拉和卡律布狄斯之间的抉择
Am J Hematol. 2012 Oct;87(10):943. doi: 10.1002/ajh.23301. Epub 2012 Jul 27.
2
Thrombopoietin receptor agonists in the treatment of immune thrombocytopenia: a clinician's perspective.血小板生成素受体激动剂治疗免疫性血小板减少症：临床医生视角
Am J Hematol. 2012 Oct;87(10):946-7. doi: 10.1002/ajh.23298. Epub 2012 Jul 27.
3
Platelet count or bleeding as the outcome in ITP trials?在免疫性血小板减少症试验中，以血小板计数还是出血情况作为结果指标？
Am J Hematol. 2012 Oct;87(10):945-6. doi: 10.1002/ajh.23299. Epub 2012 Jul 27.
4
Platelet response as the basis for approval in chronic immune (idiopathic) thrombocytopenic purpura (ITP): a regulatory perspective.以血小板反应作为慢性免疫性（特发性）血小板减少性紫癜（ITP）批准依据的监管视角。
Am J Hematol. 2012 Oct;87(10):943-4. doi: 10.1002/ajh.23300. Epub 2012 Sep 17.
5
Bleeding and mortality outcomes in ITP clinical trials: a review of thrombopoietin mimetics data.ITP 临床试验中的出血和死亡率结果：血小板生成素模拟物数据综述。
Am J Hematol. 2012 Oct;87(10):984-7. doi: 10.1002/ajh.23275. Epub 2012 Jun 22.
6
Sequential treatment with thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): experience in our center.免疫性血小板减少症（ITP）中血小板生成素受体激动剂（TPO-RAs）的序贯治疗：我们中心的经验
Ann Hematol. 2017 Mar;96(3):507-508. doi: 10.1007/s00277-016-2896-3. Epub 2016 Dec 15.
7
[Management of refractory ITP with thrombopoietin receptor agonists].[血小板生成素受体激动剂治疗难治性免疫性血小板减少症]
Rinsho Ketsueki. 2011 Aug;52(8):627-32.
8
Update on romiplostim and eltrombopag indirect comparison.罗米司亭和艾曲泊帕间接比较的最新情况。
Int J Technol Assess Health Care. 2014 Jan;30(1):129-130. doi: 10.1017/S0266462313000767. Epub 2014 Jan 31.
9
Thrombopoietin Receptor Agonists: Eltrombopag and Romiplostim for the Treatment of Chronic Immune Thrombocytopenia Purpura.血小板生成素受体激动剂：艾曲泊帕和罗米司亭用于治疗慢性免疫性血小板减少性紫癜
Clin J Oncol Nurs. 2019 Apr 1;23(2):212-216. doi: 10.1188/19.CJON.212-216.
10
Effectiveness of thrombopoietin-receptor agonists in the treatment of refractory immune thrombocytopenia associated to systemic lupus erythematosus.血小板生成素受体激动剂治疗系统性红斑狼疮相关难治性免疫性血小板减少症的疗效
J Rheumatol. 2014 Sep;41(9):1895-6. doi: 10.3899/jrheum.140080.
Zotero 插件